Patent · US Active

Beta-arrestin effectors and compositions and methods of use thereof

US8946142B2 · kind B2 · utility

2Cited by
8References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2013
Grant dateFeb 3, 2015
Priority date—
Expiry dateJan 31, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application describes compounds acting as, for example, β-arrestin effectors and uses thereof, in, for example, the treatment of chronic and acute cardiovascular diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.